SCOT Registry: Small Cell Lung Cancer Treatment and Outcome
N/A
18 Years
N/A
18 Years
N/A
Open (Enrolling)
Both
Lung Cancer, Small Cell
Both
Lung Cancer, Small Cell
Trial Information
SCOT Registry: Small Cell Lung Cancer Treatment and Outcome
Inclusion Criteria:
- Male or Female >/= 18 years
- Diagnosis of small cell lung cancer
- Patient newly diagnosed with SCLC
- Has given written informed consent (if applicable)
Exclusion Criteria:
- Concurrent history of other neoplasm, except curatively treated basal cell skin
cancer or adequately treated in-situ carcinoma of the cervix.
- Patient presenting with recurrence of SCLC.
- Patients who has received any chemotherapy for the SCLC.
Type of Study:
Observational
Study Design:
Time Perspective: Prospective
Outcome Measure:
Registry with disease, treatment and outcome data collected.
Outcome Time Frame:
6-9mth recruitment period, 18mth study duration.
Safety Issue:
No
Principal Investigator
GSK Clinical Trials
Investigator Role:
Study Director
Investigator Affiliation:
GlaxoSmithKline
Authority:
Czech Republic: Státní ústav pro kontrolu léčiv, Oddělení klinického hodnocení
Study ID:
112791
NCT ID:
NCT00997061
Start Date:
November 2009
Completion Date:
March 2013
Related Keywords:
- Lung Cancer, Small Cell
- Lung Neoplasms
- Small Cell Lung Carcinoma
Name | Location |
|---|
